Altman Peter purchased $415 of BCDA
Altman Peter (President and CEO) purchased 500 shares of BioCardia, Inc. (BCDA) at $0.83 on 2026-07-17.
How this was made
The 30-second read
Why it matters
This is a primary-source insider buy by the CEO, but the disclosed size is modest and the filing contains no new business or financial information.
Market read
Traders may view the CEO’s open-market purchase as a small positive sentiment datapoint, but it is unlikely to drive a fundamental repricing without additional catalysts.
What to watch
The filing does not include any accompanying corporate update, guidance, or material event; without context on prior transactions, signal strength is limited.
Background
The article is a SEC Form 4 insider transaction disclosure for BioCardia, Inc. (BCDA).
Ticker impact
BioCardia CEO Altman Peter bought 500 shares in an open-market transaction at $0.8300/share, disclosed via Form 4 filed July 20.
Likely limited near-term price impact; any effect would be incremental sentiment rather than a catalyst.
Form 4 confirms the transaction details (shares, price, total value) and insider role, but the article provides no operational or financial change that would re-rate the business.
Market effects
No sector read-through is provided beyond a single-company insider transaction.
None indicated.
None indicated.
Counterpoint
Insider buys can be routine, tax- or compensation-related, and the small $415 value may not signal a meaningful change in outlook.
Key entities
- issuerBioCardia, Inc.
Company whose CEO insider purchase is disclosed on Form 4.
- insiderAltman Peter
President and CEO who purchased 500 shares at $0.8300/share.